Goodluck Okoro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Goodluck Okoro has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Chinmaya Mutalik
Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei11031, Taiwan
3 shared publicationsSibidou Yougbaré
Institut de Recherche en Sciences de La Santé/Direction Régionale du Centre Ouest (IRSS/DRCO), Nanoro11 BP 218, Burkina Faso
3 shared publications- Tsung-Rong Kuo
International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
3 shared publications I-Hsin Lin
School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan
2 shared publications- Michael B. Nelappana
Department of Bioengineering, University of Illinois at Urbana−Champaign, Urbana, IL 61801, USA
2 shared publications - Wawrzyniec Lawrence Dobrucki
Department of BioEngineering, University of Illinois Urbana Champaign, Urbana, USA
2 shared publications
Latest Publications
- Open Access
- 16 December 2025
- Published by Elsevier in Physica Medica
- Vol. 141, 105694
Enhancing radiomic feature selection in PET-based heterogeneity analysis through tumor-volume-weighted normalization
- 16 December 2025
- Published by Elsevier in Physica Medica
- Vol. 141, 105694
Open AccessEnhancing radiomic feature selection in PET-based heterogeneity analysis through tumor-volume-weighted normalization
- Open Access
- 1 December 2025
- Published by IOP Publishing in Progress in Biomedical Engineering
- Vol. 8 (1) , 012006
Cutting-edge approaches to diagnosing and treating limb ischemia in peripheral arterial disease
Peripheral arterial disease (PAD) is a common circulatory condition that leads to reduced blood flow to the limbs, often resulting in limb ischemia which can severely impact a patient’s quality of life and increase the risk of amputation. Early diagnosis and timely intervention are critical in managing PAD-associated limb ischemia. This review provides a comprehensive overview of the latest diagnostic and therapeutic approaches for PAD and limb ischemia. We explored both non-invasive and invasive diagnostic techniques including ankle–brachial index, duplex ultrasonography, magnetic resonance angiography, computed tomography angiography and emerging technologies like molecular imaging and near-infrared spectroscopy. Therapeutic strategies discussed include pharmacological treatments such as antiplatelet agents and statins, endovascular interventions like angioplasty and stenting as well as advanced options such as gene and stem cell therapies. Emerging treatments including non-thermal plasma and extracellular vesicle therapy are also highlighted for their regenerative potential. We have also addressed the challenges of current approaches, including diagnostic limitations, barriers to new therapies and cost considerations aimed at improving outcomes for PAD patients.
- 1 December 2025
- Published by IOP Publishing in Progress in Biomedical Engineering
- Vol. 8 (1) , 012006
Open AccessCutting-edge approaches to diagnosing and treating limb ischemia in peripheral arterial disease
Peripheral arterial disease (PAD) is a common circulatory condition that leads to reduced blood flow to the limbs, often resulting in limb ischemia which can severely impact a patient’s quality of life and increase the risk of amputation. Early diagnosis and timely intervention are critical in managing PAD-associated limb ischemia. This review provides a comprehensive overview of the latest diagnostic and therapeutic approaches for PAD and limb ischemia. We explored both non-invasive and invasive diagnostic techniques including ankle–brachial index, duplex ultrasonography, magnetic resonance angiography, computed tomography angiography and emerging technologies like molecular imaging and near-infrared spectroscopy. Therapeutic strategies discussed include pharmacological treatments such as antiplatelet agents and statins, endovascular interventions like angioplasty and stenting as well as advanced options such as gene and stem cell therapies. Emerging treatments including non-thermal plasma and extracellular vesicle therapy are also highlighted for their regenerative potential. We have also addressed the challenges of current approaches, including diagnostic limitations, barriers to new therapies and cost considerations aimed at improving outcomes for PAD patients.
- Open Access
- 1 December 2022
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 5 (1) , 95-115
Emerging Trends in Nanomaterials for Photosynthetic Biohybrid Systems
- 1 December 2022
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 5 (1) , 95-115
Open AccessEmerging Trends in Nanomaterials for Photosynthetic Biohybrid Systems
- Open Access
- 28 June 2022
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 10 (27) , 8949-8957
Phase-Dependent 1T/2H-MoS2 Nanosheets for Effective Photothermal Killing of Bacteria
- 28 June 2022
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 10 (27) , 8949-8957
Open AccessPhase-Dependent 1T/2H-MoS2 Nanosheets for Effective Photothermal Killing of Bacteria
- Open Access
- 1 August 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 5831-5867
Emerging Trends in Nanomaterials for Antibacterial Applications
Around the globe, surges of bacterial diseases are causing serious health threats and related concerns. Recently, the metal ion release and photodynamic and photothermal effects of nanomaterials were demonstrated to have substantial efficiency in eliminating resistance and surges of bacteria. Nanomaterials with characteristics such as surface plasmonic resonance, photocatalysis, structural complexities, and optical features have been utilized to control metal ion release, generate reactive oxygen species, and produce heat for antibacterial applications. The superior characteristics of nanomaterials present an opportunity to explore and enhance their antibacterial activities leading to clinical applications. In this review, we comprehensively list three different antibacterial mechanisms of metal ion release, photodynamic therapy, and photothermal therapy based on nanomaterials. These three different antibacterial mechanisms are divided into their respective subgroups in accordance with recent achievements, showcasing prospective challenges and opportunities in clinical, environmental, and related fields.
- 1 August 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 5831-5867
Open AccessEmerging Trends in Nanomaterials for Antibacterial Applications
Around the globe, surges of bacterial diseases are causing serious health threats and related concerns. Recently, the metal ion release and photodynamic and photothermal effects of nanomaterials were demonstrated to have substantial efficiency in eliminating resistance and surges of bacteria. Nanomaterials with characteristics such as surface plasmonic resonance, photocatalysis, structural complexities, and optical features have been utilized to control metal ion release, generate reactive oxygen species, and produce heat for antibacterial applications. The superior characteristics of nanomaterials present an opportunity to explore and enhance their antibacterial activities leading to clinical applications. In this review, we comprehensively list three different antibacterial mechanisms of metal ion release, photodynamic therapy, and photothermal therapy based on nanomaterials. These three different antibacterial mechanisms are divided into their respective subgroups in accordance with recent achievements, showcasing prospective challenges and opportunities in clinical, environmental, and related fields.